Advertisement
Advertisement
ESLA
Estrella Immunopharma, Inc. Common Stock
0.98
USDSponsored
-0.02
-2.00%
Jun 24, 15:59 UTC -4
Closed
After-Market
0.98
0.00
+0.41%
ESLA Earnings Reports
Positive Surprise Ratio
ESLA beat 2 of 4 last estimates.
50%
Next Report
Date of Next Report
Nov 10, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$0.13
Implied change from Q2 26 (Revenue/ EPS)
--
/-62.86%
Implied change from Q3 25 (Revenue/ EPS)
--
/--
Estrella Immunopharma, Inc. Common Stock earnings per share and revenue
On Mar 18, 2026, ESLA reported earnings of -0.35 USD per share (EPS) for Q2 26, missing the estimate of -0.18 USD, resulting in a -90.63% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.70% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of -0.13 USD, with revenue projected to reach -- USD, implying an decrease of -62.86% EPS, and increase of 0.00% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Prenetics Global Limited Class A Ordinary Share
Report Date
Jun 10, 2026 For Q1 26
Estimate
-$1.10
Actual
-$1.61
Surprise
-45.36%
Anixa Biosciences, Inc.
Report Date
Jun 10, 2026 For Q2 26
Estimate
-$0.08
Actual
-$0.07
Surprise
+21.61%
FAQ
What were Estrella Immunopharma, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Estrella Immunopharma, Inc. Common Stock reported EPS of -$0.35, missing estimates by -90.63%, and revenue of $0.00, 0% as expectations.
How did the market react to Estrella Immunopharma, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -2.7%, changed from $1.11 before the earnings release to $1.08 the day after.
When is Estrella Immunopharma, Inc. Common Stock expected to report next?
The next earning report is scheduled for Nov 10, 2026.
What are the forecasts for Estrella Immunopharma, Inc. Common Stock's next earnings report?
Based on 3
analysts, Estrella Immunopharma, Inc. Common Stock is expected to report EPS of -$0.13 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement